New Alzheimer's Drug May Help Mildly Impaired

Wednesday, 16 Jul 2014 12:34 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Researchers say an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease.
The drug did show some promise in the least-impaired participants who received the higher of two doses in the mid-stage studies.

The drug, crenezumab (cruh-NEZ-oo-mab), aims to clear away the sticky amyloid plaques clogging Alzheimer's patients' brains.

The company says it is encouraged by the possible benefit for mildly impaired patients and will talk with regulators about the next steps to test the drug.

Results were discussed Wednesday at the Alzheimer's Association International Conference in Copenhagen.
 

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Indoor Fall Is Danger Sign for Seniors: Study

Thursday, 18 Sep 2014 17:06 PM

Women in their eighties who fell indoors, rather than outdoors or from a height like a ladder, died sooner than their pe . . .

One Dose of Antidepressant Changes Brain Connections: Study

Thursday, 18 Sep 2014 17:01 PM

Just a single dose of a common antidepressant can quickly alter theway brain cells communicate with one another, early r . . .

Researchers: Sit Less, Live Longer

Thursday, 18 Sep 2014 15:30 PM

New research shows that sitting less can slow the aging process and contribute to longer life. The findings, from two ne . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved